A living model of the human lung, complete with fully connected airways and gas-exchange sacs, is being built from a single patient’s own cells. Current lab models of the lung only mimic isolated parts—either the airways or the alveoli—but never the whole, continuous structure. This means researchers cannot study how inhaled pollutants travel from the windpipe to the deepest sacs, or how a drug designed for one region affects another. The iLUNG aims to close that gap by engineering a multicellular, integrated replica that preserves the lung’s branching architecture and function. If successful, the iLUNG could transform how lung diseases are studied and treated. Because each model is built from an individual patient’s cells, it could reveal why one person responds to a therapy while another does not, enabling more targeted treatments. It would also give pharmaceutical companies a realistic platform to test inhaled drugs and assess environmental pollutants without animal models. The team intends to make the technology widely available to academia and industry, with the goal of becoming both a scientific and commercial tool for lung research.
View original technical description
The human respiratory system exists to perform gas exchange and thus support life. The entire cellular surface of the lung is continuous with air from the main airways, to tree-like branched airways and the sacs where gas exchange happens - these are called alveoli. Although there has been great progress in laboratory models of individual parts of the lung, they do not have this feature of functional evolution from the airways to the the alveoli. The absence of integrated models has hampered progress in understanding lung physiology and what happens in lung disease. Further, key societal issues like the development of new inhaled treatments for specific diseases and an understanding of what environmental pollution does to the lung would be really enhanced by better models. In this project, we aim to engineer a living model of the human lung where the airway to the alveolar sacs are fully connected and functional. We call it the iLUNG. A key advantage of our work is that we will use multiple cell types from an individual patient to create them. This means that they will be truly individualised "mini-lungs" and will therefore hopefully reflect the disease associated with the person that we grew the cells from. This opens up the possibility of more targeted treatments for lung disease as well new possibilities to understand basic lung biology and how different types of cells in the lung talk to each other. We have put together a great team of lung bioengineers for this proposal and have the engineering and scientific infrastructure as well as access to patients to make this project deliverable. We are tremendously excited by the potential of the iLUNG and are fully motivated to train the next generation of lung bioengineers. Finally we are clear that we want this technology to be used widely in academia and industry and eventually be both a scientific and commercial success.
Frank McCaughan (Principal Investigator)Joo-Hyeon Lee (Co-Investigator)Namshik Han (Co-Investigator)Nicholas Morrell (Co-Investigator)Yan Huang (Co-Investigator)
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know